文献速递眼底病与葡萄膜炎

年龄相关性黄斑变性患者皮肤角质形成细胞性与黑色素细胞性恶性肿瘤发生率增加

INCREASED INCIDENCE OF CUTANEOUS KERATINOCYTIC AND MELANOCYTIC MALIGNANCIES IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION.
PubMed 文献 · Retina · 2020-01-01

该回顾性连续队列研究基于明尼苏达州奥姆斯特德县罗切斯特流行病学计划,纳入2004年1月1日至2013年12月31日期间因湿性年龄相关性黄斑变性(AMD)接受至少1次玻璃体内注射的患者,并与年龄、性别匹配的473例抗血管内皮生长因子时代前湿性AMD患者、504例同期干性AMD患者及504例无AMD患者比较。结果显示湿性AMD患者总体恶性肿瘤和皮肤恶性肿瘤发生率均高于干性AMD及无AMD者,干性AMD患者恶性肿瘤发生率亦高于无AMD者。作者认为这是首次报告AMD与皮肤恶性肿瘤之间的关联。

要点

  • 湿性AMD患者总体恶性肿瘤发生率为52.8%,高于干性AMD的43.7%和无AMD的35.3%。
  • 湿性AMD患者皮肤恶性肿瘤发生率为24.4%,高于干性AMD的14.6%和无AMD的9.7%。
  • 干性AMD患者总体恶性肿瘤发生率43.7%高于无AMD者的35.3%(P=0.007)。

核心结论

  • 湿性AMD患者总体恶性肿瘤及皮肤恶性肿瘤发生率高于干性AMD和无AMD患者,干性AMD患者总体恶性肿瘤发生率亦高于无AMD患者;作者认为这是首次确立AMD与皮肤恶性肿瘤之间关联的报告,支持在患者出现这两种情况之一时对关联进行可能的讨论。

研究设计与样本

  • 回顾性连续队列研究,使用明尼苏达州奥姆斯特德县罗切斯特流行病学计划数据,纳入2004年1月1日至2013年12月31日期间因湿性AMD接受至少1次玻璃体内注射的全部患者。
  • 对照为年龄和性别匹配的473例抗血管内皮生长因子时代前湿性AMD患者、504例同期干性AMD患者和504例无AMD患者,比较各组AMD、总体恶性肿瘤、皮肤恶性肿瘤及特定类型皮肤恶性肿瘤的发生率。

临床怎么用

  • 作者认为该关联支持在患者出现AMD或皮肤恶性肿瘤之一时,对两者关联进行可能的讨论。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The relationship between age-related macular degeneration (AMD) and malignancy, especially cutaneous malignancies, is not well studied. We investigated a possible association between AMD and cutaneous malignancies. METHODS: A retrospective, consecutive review of all patients who had received at least 1 intravitreal injection for wet AMD between January 1, 2004, and December 31, 2013, was conducted using the Rochester Epidemiology Project in Olmsted County, Minnesota. Age- and sex-matched control groups included 473 pre-anti-vascular endothelial growth factor era wet AMD patients, 504 concurrent time dry AMD patients, and 504 patients with no AMD. The rates of AMD and overall malignancy, cutaneous malignancies, and specific types of cutaneous malignancies were compared between groups of patients. RESULTS: Patients with wet AMD incurred an increased rate of overall malignancies compared to patients with dry AMD {52.8% wet AMD (confidence interval [CI]: 48.3-57.2) vs. 43.7% dry AMD (CI: 39.3-48.1); P= 0.003} or those without AMD (52.8% wet AMD [CI: 48.3-57.2] vs. 35.3% no AMD [CI: 31.1-39.7]; P = <0.001). Patients with dry AMD also had higher rates of malignancy than those without AMD (43.7% dry AMD [CI: 39.3-48.1] vs. 35.3% no AMD [CI: 31.1-39.7]; P = 0.007). Rate of cutaneous malignancies was increased in patients with wet AMD compared to patients with dry AMD (24.4% wet AMD [CI: 20.7-28.4] vs. 14.6% dry AMD [CI: 11.5-17.9]; P = <0.001) and those with no AMD (24.4% wet AMD [CI: 20.7-28.4] vs. 9.7% no AMD [CI: 7.3-12.7]; P = <0.001). CONCLUSION AND RELEVANCE: To the best of our knowledge, this is the first report to establish an association between AMD and cutaneous malignancies, supporting a possible discussion of the association when a patient presents with one of the two conditions.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Shah SM, Starr MR, Dalvin LA, et al. INCREASED INCIDENCE OF CUTANEOUS KERATINOCYTIC AND MELANOCYTIC MALIGNANCIES IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION. Retina. 2020. PMID: 30986797. doi:10.1097/IAE.0000000000002506

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。